Target intelligence / Profile preview

Solute carrier family 15 member 1 (SLC15A1)

Target
SLC15A1
Molecular classification
Transporter, Membrane protein, Proton-coupled oligopeptide transporter (POT family), Major facilitator superfamily (MFS)
01

Overview

Solute carrier family 15 member 1 (SLC15A1), commonly known as Peptide transporter 1 (PEPT1), is a proton-coupled oligopeptide transporter primarily localized to the apical membrane of enterocytes in the small intestine. It mediates the uptake of di- and tripeptides, a critical step in dietary protein assimilation, by coupling peptide influx with a proton gradient across the membrane. SLC15A1 also enables the absorption of numerous peptidomimetic drugs, including many β-lactam antibiotics, ACE inhibitors, and antiviral prodrugs, making it highly relevant in pharmacology and drug development. It plays a similar, albeit less prominent, role in renal peptide reabsorption. Alterations in its expression or function can influence disease risk (such as inflammatory bowel disease) and affect the pharmacokinetics of orally administered drugs, positioning SLC15A1 as both a key biological transporter and a significant therapeutic target[1][2][3][5].

Other names
Peptide transporter 1PEPT1Intestinal H+/peptide cotransporterOligopeptide transporter 1HPEPT1HPECT1Caco-2 oligopeptide transporterbA551M18.1.1Small intestine isoformMacrophage oligopeptide transporter PEPT1
02

Mechanism of action

Proton-coupled symport, transporting di- and tripeptides (and structurally related drugs) into cells by utilizing the inward electrochemical proton gradient Increases oral bioavailability of peptidomimetic drugs by enabling intestinal uptake

03

Biological functions

Uptake and absorption of di- and tripeptides from the intestinal lumen into enterocytesDigestion and assimilation of dietary proteinsProton-driven cotransport of peptidesAbsorption of peptidomimetic drugs and therapeutic agentsReabsorption of filtered peptides in the kidneyContribution to mucosal immune response via transport of bacterial peptide ligands
04

Disease associations

Inflammatory bowel disease (genetic variations in SLC15A1 may confer predisposition)Meckel diverticulum (association noted)Hartnup disorder (association noted)Role in pharmacokinetics and drug absorption (altered function may impact drug bioavailability)
05

Safety considerations

Drug-drug interactions affecting absorption of SLC15A1 substrates may impact efficacy or toxicityAlterations in transporter function could influence nutrient absorption and drug pharmacokineticsUpregulation in disease states (e.g., inflammatory bowel disease) may affect drug response
06

Interacting drugs

β-lactam antibiotics (e.g., cefadroxil, amoxicillin)

3 more in the full profile.

07

Biomarkers

SLC15A1 expression levels in the small intestine may serve as a biomarker for oral peptide drug absorption or efficacyGenetic variants (e.g., Ser117Asn SNP) associated with disease or altered function may inform precision medicine applications

Beyond the preview

Go deeper on Solute carrier family 15 member 1 (SLC15A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 15 member 1 (SLC15A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call